tert-Butyl 4,4-difluoropiperidine-1-carboxylate, 95.0%, 10g

2-[Bis[2-(1-methylethyl)phenyl]phosphino]-N-[(9R)-6?-methoxycinchonan-9-yl]benzamide, 50mg

11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine, 97.0%, 10mg

4-Nitrobenzophenone, 95.0%, 25g

(5-Methyl-3-phenyl-1H-pyrazol-1-yl)methanol, 95.0%, 5g

Pipettenspitzen UNIVERSAL 5–200 μl mit Graduierung, Beutel, 25.000 Stück, unsteril, 25.000 Stück

ethyl 3-[(4-phenylbutan-2-yl)amino]propanoate, 95.0%, 10g

METHYL [1,2,4]TRIAZOLO[1,5-A]PYRIDINE-8-CARBOXYLATE, 95%, 25g

N-METHYL-N-[(3R)-PYRROLIDIN-3-YL]METHANESULFONAMIDE HCL, 95.0%, 100mg

Antimon Pulver, min. 99,5 %, ca. 325 mesh, 500 g, kunststoffverpackung.

(5-TERT-BUTYL-1,3-PHENYLENE)DIMETHANOL, 95.0%, 250mg

2-Bromo-5-iodobenzotrifluoride, 95.0%, 1g

4-Bromoindoline hydrochloride, 95.0%, 25g